186 related articles for article (PubMed ID: 7773170)
21. Design and biological evaluation of linear and cyclic phosphopeptide ligands of the N-terminal SH2 domain of protein tyrosine phosphatase SHP-1.
Imhof D; Wieligmann K; Hampel K; Nothmann D; Zoda MS; Schmidt-Arras D; Zacharias M; Böhmer FD; Reissmann S
J Med Chem; 2005 Mar; 48(5):1528-39. PubMed ID: 15743195
[TBL] [Abstract][Full Text] [Related]
22. Sequence specificity in the recognition of the epidermal growth factor receptor by the abl Src homology 2 domain.
Zhu G; Decker SJ; Maclean D; McNamara DJ; Singh J; Sawyer TK; Saltiel AR
Oncogene; 1994 May; 9(5):1379-85. PubMed ID: 8152798
[TBL] [Abstract][Full Text] [Related]
23. Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584.
Vogel W; Ullrich A
Cell Growth Differ; 1996 Dec; 7(12):1589-97. PubMed ID: 8959326
[TBL] [Abstract][Full Text] [Related]
24. A new function for phospholipase C-gamma1: coupling to the adaptor protein GRB2.
Pei Z; Maloney JA; Yang L; Williamson JR
Arch Biochem Biophys; 1997 Sep; 345(1):103-10. PubMed ID: 9281317
[TBL] [Abstract][Full Text] [Related]
25. Cutting edge: association of phospholipase C-gamma 2 Src homology 2 domains with BLNK is critical for B cell antigen receptor signaling.
Ishiai M; Sugawara H; Kurosaki M; Kurosaki T
J Immunol; 1999 Aug; 163(4):1746-9. PubMed ID: 10438904
[TBL] [Abstract][Full Text] [Related]
26. Mutational investigation of the specificity determining region of the Src SH2 domain.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
[TBL] [Abstract][Full Text] [Related]
27. Phosphopeptide ligands of the SHP-1 N-SH2 domain: effects on binding and stimulation of phosphatase activity.
Hampel K; Kaufhold I; Zacharias M; Böhmer FD; Imhof D
ChemMedChem; 2006 Aug; 1(8):869-77. PubMed ID: 16902940
[TBL] [Abstract][Full Text] [Related]
28. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646
[TBL] [Abstract][Full Text] [Related]
29. Intramolecular interaction between phosphorylated tyrosine-783 and the C-terminal Src homology 2 domain activates phospholipase C-gamma1.
Poulin B; Sekiya F; Rhee SG
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4276-81. PubMed ID: 15764700
[TBL] [Abstract][Full Text] [Related]
30. SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase C gamma.
Rotin D; Margolis B; Mohammadi M; Daly RJ; Daum G; Li N; Fischer EH; Burgess WH; Ullrich A; Schlessinger J
EMBO J; 1992 Feb; 11(2):559-67. PubMed ID: 1537335
[TBL] [Abstract][Full Text] [Related]
31. A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1.
Mohammadi M; Honegger AM; Rotin D; Fischer R; Bellot F; Li W; Dionne CA; Jaye M; Rubinstein M; Schlessinger J
Mol Cell Biol; 1991 Oct; 11(10):5068-78. PubMed ID: 1656221
[TBL] [Abstract][Full Text] [Related]
32. Differential association of cytoplasmic signalling molecules SHP-1, SHP-2, SHIP and phospholipase C-gamma1 with PECAM-1/CD31.
Pumphrey NJ; Taylor V; Freeman S; Douglas MR; Bradfield PF; Young SP; Lord JM; Wakelam MJ; Bird IN; Salmon M; Buckley CD
FEBS Lett; 1999 Apr; 450(1-2):77-83. PubMed ID: 10350061
[TBL] [Abstract][Full Text] [Related]
33. SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides.
Case RD; Piccione E; Wolf G; Benett AM; Lechleider RJ; Neel BG; Shoelson SE
J Biol Chem; 1994 Apr; 269(14):10467-74. PubMed ID: 8144631
[TBL] [Abstract][Full Text] [Related]
34. Sequence specificity in recognition of the epidermal growth factor receptor by protein tyrosine phosphatase 1B.
Milarski KL; Zhu G; Pearl CG; McNamara DJ; Dobrusin EM; MacLean D; Thieme-Sefler A; Zhang ZY; Sawyer T; Decker SJ
J Biol Chem; 1993 Nov; 268(31):23634-9. PubMed ID: 7693694
[TBL] [Abstract][Full Text] [Related]
35. Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides.
Bibbins KB; Boeuf H; Varmus HE
Mol Cell Biol; 1993 Dec; 13(12):7278-87. PubMed ID: 7504171
[TBL] [Abstract][Full Text] [Related]
36. Demonstration of functionally different interactions between phospholipase C-gamma and the two types of platelet-derived growth factor receptors.
Eriksson A; Nånberg E; Rönnstrand L; Engström U; Hellman U; Rupp E; Carpenter G; Heldin CH; Claesson-Welsh L
J Biol Chem; 1995 Mar; 270(13):7773-81. PubMed ID: 7535778
[TBL] [Abstract][Full Text] [Related]
37. Src homology-2 domains protect phosphotyrosyl residues against enzymatic dephosphorylation.
Brunati AM; Pinna LA; Bergantino E; Ruzzene M; Cirri P; Ramponi G; Donella-Deana A
Biochem Biophys Res Commun; 1998 Feb; 243(3):700-5. PubMed ID: 9500984
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of binding of phospholipase C gamma 1 SH2 domains to phosphorylated epidermal growth factor receptor by phosphorylated peptides.
McNamara DJ; Dobrusin EM; Zhu G; Decker SJ; Saltiel AR
Int J Pept Protein Res; 1993 Sep; 42(3):240-8. PubMed ID: 8225779
[TBL] [Abstract][Full Text] [Related]
39. Construction of an SH2 domain-binding site with mixed specificity.
Larose L; Gish G; Pawson T
J Biol Chem; 1995 Feb; 270(8):3858-62. PubMed ID: 7876130
[TBL] [Abstract][Full Text] [Related]
40. Localization of the insulin-like growth factor I receptor binding sites for the SH2 domain proteins p85, Syp, and GTPase activating protein.
Seely BL; Reichart DR; Staubs PA; Jhun BH; Hsu D; Maegawa H; Milarski KL; Saltiel AR; Olefsky JM
J Biol Chem; 1995 Aug; 270(32):19151-7. PubMed ID: 7642582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
